| Cost-effectiveness of Post-Mastectomy Radiotherapy (PMRT) for breast cancer in India: An economic modelling study | | 2022 |
| Cost‐effectiveness analysis of the new oncological drug durvalumab in Italian patients with stage III non‐small cell lung cancer | | |
| Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer: Lessons Learned and Future Perspectives | | 2022 |
| Impact of adjuvant chemotherapy on T1N0M0 breast cancer patients: a propensity score matching study based on SEER database and external cohort | | 2022 |
| Emerging Biomarker-Guided Therapies in Prostate Cancer | Current Oncology | 2022 |
| Nivolumab plus ipilimumab in malignant pleural mesothelioma | Expert Review of Anticancer Therapy | |
| Prognostic markers including immune and inflammatory factors predict outcomes in patients receiving postoperative radiation therapy for cholangiocarcinoma | Asia-Pacific Journal of Clinical Oncology | |
| Renal tumor biopsy in patients with cT1b-T4-M0 disease susceptible to radical nephrectomy: analysis of safety, accuracy and clinical impact on definitive management | Scandinavian Journal of Urology | |
| Nutritional Status and Related Factors in Patients with Gastric Cancer after Gastrectomy: A Cross-Sectional Study | Nutrients | 2022 |
| Nomograms for primary mucinous ovarian cancer: A SEER population-based study | Journal of Gynecology Obstetrics and Human Reproduction | 2022 |
| Knowledge, attitudes, and practices of active surveillance in prostate cancer among urologists: a real-life survey from Brazil | BMC Urology | 2022 |
| Anal Cancer: Emerging Standards in a Rare Rare Disease | Journal of Clinical Oncology | |
| Memantine in the Prevention of Radiation-Induced Brain Damage: A Narrative Review | Cancers | 2022 |
| New Achievements for the Treatment of Triple-Negative Breast Cancer | Applied Sciences (Switzerland) | 2022 |
| Chemo-Immunotherapy Regimes for Recurrent or Metastatic Nasopharyngeal Carcinoma: A Network Meta-Analysis and Cost-Effectiveness Analysis | Frontiers in Pharmacology | 2022 |
| Real-World Treatment Patterns and Clinical Outcomes in Patients With Stage III Non-Small-Cell Lung Cancer: Results of KINDLE-Vietnam Cohort | Frontiers in Oncology | 2022 |
| Metastatic pheochromocytomas and paragangliomas: where are we? | Tumori | 2022 |
| The Tale of a Rubbery White Clot: Poorly Differentiated Spindle Cell Sarcoma Presenting As Superior Vena Cava Syndrome | Cureus | 2022 |
| Cost-Effectiveness and Budget Impact Analyses of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia from the Singapore Healthcare System Perspective. | ClinicoEconomics and Outcomes Research | 2022 |
| Team-Based Hospice Referrals: A Potential Quality Metric for Lung Cancer in the Immunotherapy Era. | American Journal of Hospice and Palliative Medicine | 2022 |
| Efficacy and safety of carfilzomib-lenalidomide-dexamethasone in newly diagnosed multiple myeloma: pooled analysis of four single-arm studies. | Leukemia and Lymphoma | 2022 |
| A real-world retrospective study of the use of Ki-67 testing and treatment patterns in patients with HR+, HER2- early breast cancer in the United States. | BMC Cancer | 2022 |
| Latissimus dorsi myocutaneous flap repair is effective after neoadjuvant chemotherapy for locally advanced breast cancer. | World Journal of Surgical Oncology | 2022 |
| Spatial analysis of tumor-infiltrating lymphocytes in histological sections using deep learning techniques predicts survival in colorectal carcinoma. | Journal of Pathology: Clinical Research | 2022 |
| Data_Sheet_1.docx | | 2020 |
| Table_4.DOCX | | 2020 |
| Table_3.DOCX | | 2020 |
| Table_2.DOCX | | 2020 |
| Table_1.DOC | | 2020 |
| Image_6.TIF | | 2020 |
| Image_5.TIF | | 2020 |
| Image_4.TIF | | 2020 |
| Image_3.TIF | | 2020 |
| Image_2.TIF | | 2020 |
| Image_1.TIF | | 2020 |
| Table_1.docx | | 2020 |
| Data_Sheet_1.pdf | | 2020 |
| DataSheet_1.docx | | 2020 |
| Image_1.tif | | 2020 |
| DataSheet_1.zip | | 2020 |
| First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study. | British Journal of Cancer | 2022 |
| Effectiveness and safety of sorafenib for renal cell, hepatocellular and thyroid carcinoma: pooled analysis in patients with renal impairment. | Cancer Chemotherapy and Pharmacology | 2022 |
| A prospective cohort study to evaluate the incidence of febrile neutropenia in patients receiving pegfilgrastim on-body injector versus other options for prophylaxis of febrile neutropenia: breast cancer subgroup analysis. | Supportive Care in Cancer | 2022 |
| The Uncertain Benefit of Adjuvant Chemotherapy in Advanced Low-Grade Serous Ovarian Cancer and the Pivotal Role of Surgical Cytoreduction. | Journal of Clinical Medicine | 2021 |
| Clinical Significance of the Prealbumin Level in Gastric Cancer Patients Who Receive Curative Treatment. | Journal of Gastrointestinal Cancer | 2021 |
| HER2 (ERBB2) alterations in colorectal cancers | Human Pathology Reports | 2022 |
| Pyrotinib-Containing Neoadjuvant Therapy in Patients With HER2-Positive Breast Cancer: A Multicenter Retrospective Analysis. | Frontiers in Oncology | 2022 |
| Population-based estimates of overtreatment with adjuvant systemic therapy in early breast cancer patients with data from the Netherlands and the USA. | Breast Cancer Research and Treatment | 2022 |
| Detection of germline variants in Brazilian breast cancer patients using multigene panel testing. | Scientific Reports | 2022 |
| Biomarker Testing Patterns and Treatment Outcomes in Patients With Advanced Non-Small Cell Lung Cancer and Exon 14 Skipping Mutations: A Descriptive Analysis From the US. | Frontiers in Oncology | 2022 |
